United States · Markets & Finance · Yahoo Finance

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

Published by Yahoo Finance · United States 15 h ago

SAN CARLOS, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the pricing of concurrent underwritten public…

Read the full article on Yahoo Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

Seeking Alpha

Ballard secures 4.8 MW order for Romania’s first hydrogen train fleet

CNBC

India’s central bank hikes rates for the first time since 2023 as inflation risks build

CoinDesk

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

Share

Also worth reading

Ballard secures 4.8 MW order for Romania’s first hydrogen train fleet

India’s central bank hikes rates for the first time since 2023 as inflation risks build

Pudgy Penguins’ Abstract becomes second Ethereum layer 2 to shut in a week

Jamie Dimon says Anthropic's Mythos supercharged AI cybersecurity risks

How Trump’s Tariff War With Canada Ensnared the Can-Am Spyder

Bitcoin.de trading remains halted as German regulator rejects MiCA application